eISSN: 1994-4624 / ISSN: 1813-176x
Register
Login
International Journal of Molecular Medicine and Advance Sciences
2005, Volume 1, Issue 2 : 88-92 doi: ijmmas.2005.88.92
Research Article
Detection of Newcastle Disease Virus in Clinical Samples from Experimentally Infected Chickens using Nested RT-PCR Assay
Published
June 30, 2005
Abstract

In this study, a nested Reverse Transcriptase (RT) polymerase chain reaction (RT-PCR)-based assay, for detection of Newcastle Disease Virus (NDV) Ribonucleic acid (RNA) in clinical samples from experimentally infected chicks, was evaluated. The clinical samples used included, blood, tracheal, cloacal, liver, spleen, heart, lung, kidney and brain. The nested RT-PCR was performed in two amplification steps. In the first step, a pair of primers (nd and nd ) was used to amplify a 356 bp specific region in the F gene of NDV. In the second step, a nested pair of primers (nd and nd ) was employed to produce 216 bp amplification products, internal to the annealing sites of primers nd and nd . The 356 bp PCR products were amplified only from lung homogenate, cloacal and tracheal tissues, kidney, heart and brain. However, the 216 bp nested amplification was detected in all tissue samples collected from experimentally infected chicks. The nested amplification confirmed the identity of the first amplified product and increased the sensitivity of RT-PCR assay. RNA samples extracted from Infectious Bursal Disease Virus (IBDV) and Infectious Bronchitis virus (IBV) or total nucleic acid extracted from blood of non infected birds failed to demonstrate the primary or the nested PCR products. The described nested RT-PCR assay provide reliable, rapid, sensitive and specific diagnostic assay for detection of an outbreak of NDV infection among susceptible Birds.

Keywords
License
Copyright (c) International Journal of Molecular Medicine and Advance Sciences
Creative Commons Attribution License Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
Int. J. Mol. Med. Adv. Sci. open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Recommended Articles
Clinical Efficacy of Drug-Eluting Stents Among Hypertensive Patients
41-45
Occupational Health Risks Among Healthcare Workers: Prevalence, Determinants, Clinical Consequences, and Prevention Strategies
1-4
Healthcare Disparities and Equity in Medical Services: Challenges, Determinants, and Strategies for Achieving Equitable Healthcare
27-34
Assessment of Research Competency Among Medical Students: Knowledge, Skills, Attitudes, and Educational Implications
22-27
International Journal of Molecular Medicine and Advance Sciences
+447480266638
+447480266638
support@ijmmas.com
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives (CC BY-NC-ND) license. Open Access Publication.
Copyright © ©International Journal of Molecular Medicine and Advance Sciences. All rights reserved.